Home
Markets
Charts & Ideas
Algo
News
Store
Brokers
Download
Economic Calendar
Trading Signals
WebTerminal
Heatmap
Type
/
to search: @user, $symbol
Search
Log in
Create an account
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Italiano
Türkçe
CNTA
#3794
Centessa Pharmaceuticals plc - American Depositary Shares
0.4
0
USD
-99.00%
Sector:
Healthcare
Base:
USD
Profit Currency:
USD
Daily Range
Year Range
Daily Change
-99.00%
Monthly Change
-98.99%
6 month change
-98.63%
Year Change
-98.38%
Previous Close
39.8
1
Open
0.4
0
Low
0.4
0
High
0.4
0
Volume
21
Markets
US Stock Market
Healthcare
CNTA
Open full chart
Full chart
Financials
Overview
Statement
Statistics
Quarterly
Annual
Value
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
Q1, 26
Current
Key stats
Total common shares outstanding
133.18 M
133.62 M
134.07 M
134.45 M
154.57 M
154.73 M
154.73 M
Valuation ratios
Enterprise value
1.96 B
1.93 B
1.83 B
3.32 B
3.91 B
6.19 B
6.19 B
Price to earnings ratio
-8.13
-7.65
-7.06
-12.76
-17.13
-22.31
-22.29
Price to sales ratio
—
125.7
115.71
215.07
226.28
—
—
Price to cash flow ratio
13.5
10.35
11.23
17.21
-17.51
-26.76
-26.73
Price to book ratio
4.78
1.05
0.97
2.15
6.44
3.34
3.34
Enterprise value to EBITDA ratio
-23.3
-57.29
-53.02
-96.86
-113.31
-106.59
-108.4
Profitability ratios
Return on assets %
-0.19
-0.05
-0.1
-0.12
-0.1
-0.12
-0.12
Return on equity %
-0.28
-0.07
-0.15
-0.18
-0.13
-0.16
-0.16
Return on invested capital %
-561.49
-89.51
-104.88
-112.21
-103.93
-95.07
-95.07
Gross margin %
—
100
—
—
—
—
—
Operating margin %
—
-205.18
—
—
—
—
—
EBITDA margin %
—
19.22
—
—
—
—
—
Net margin %
—
-174.23
—
—
—
—
—
Liquidity ratios
Quick ratio
—
—
—
—
—
—
—
Current ratio
9.25
14.37
10.12
10.57
8.57
9.53
9.53
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0
0.03
0
0
0
0
0
Solvency ratios
Debt to assets ratio
0.19
0.21
0.22
0.24
0.16
0.17
0.17
Debt to equity ratio
0.27
0.28
0.32
0.36
0.21
0.23
0.23
Long term debt to total assets ratio
0.19
0.21
0.22
0.24
0.16
0.17
0.17
Long term debt to total equity ratio
0.27
0.28
0.32
0.36
0.21
0.23
0.23
Per share metrics
Operating cash flow per share
-0.37
-0.43
-0.17
-0.43
-0.41
-0.47
-1.48
EBIT per share
-0.12
0.02
-0.09
-0.09
-0.1
-0.13
-0.41
EBITDA per share
-0.12
0.02
-0.09
-0.09
-0.1
-0.13
-0.41
Total debt per share
0.95
0.82
0.82
0.82
0.81
0.72
0.72
Cash per share
4.21
2.14
1.88
1.84
2.17
1.8
1.8
Net current asset value per share
4.69
2.61
2.25
2.29
2.71
2.27
2.27
Tangible book value per share
3.51
2.9
2.58
2.25
3.88
3.17
3.17
Working capital per share
4.18
2.43
2.02
2.08
2.39
2.03
2.03
Book value per share
3.51
2.9
2.58
2.25
3.88
3.17
3.17
News
LLY Stock Jumps After Q1 Earnings Beat, 2026 Guidance Raised
Should You Buy, Sell or Hold Lilly Stock Before Q1 Earnings?
LLY to Buy Oncology Biotech Kelonia Therapeutics for $7 Billion
Biotech Is Holding Steady In 2026 (NASDAQ:IBB)
LLY to Buy Neuroscience Biotech Centessa Pharmaceuticals in $7.8B Deal
Eli Lilly To Buy Centessa Pharma For Up To $7.8 Billion; Centessa Shares Skyrocket
Lilly to pay up to $7.8 billion to buy a company developing a narcolepsy drug
Wolfe Research initiates Centessa stock with outperform rating
Piper Sandler reiterates Overweight rating on Centessa stock ahead of catalysts
Centessa reports antidepressive effects of OX2R agonist in animal study
Centessa Pharmaceuticals stock pullback offers good entry point, says TD Cowen
MindMed stock added to Needham’s Conviction List, analyst reiterates Hold